In this post hoc analysis of PAD patients from the SILC study, metrics of HDL structure (HDL3) and function (efflux) were inversely associated with a marker of systemic inflammation (IL-6) at baseline; however, the association of IL-6 with HDL efflux was lost after adjustment for comorbidities and HDL3. Here, IL6 is linked to peripheral arterial disease.